Kuehne + Nagel Becomes Global Transportation Provider for the Grünenthal Group
Kuehne + Nagel has come to an agreement with pharmaceutical research company Grünenthal for the transportation of their land, air and sea freight. Kuehne + Nagel is supporting the Grünenthal Group with the reorganization of the world-wide transportation network for highly sensitive pharmaceutical products.
International research-based pharmaceutical company Grünenthal is headquartered in Aachen, Germany. They have production sites in Europe and Latin America and their products are available in 155 countries. In order to supply all its sites, Grünenthal needed a partner operating on a global scale who meets the company’s extremely high demands in terms of reliability and traceability.
Kuehne + Nagel and Grünenthal are working together to develop a solution that is tailored to the requirements of the Grünenthal Group with KN PharmaChain as its core element. Kuehne + Nagel recently became the first logistics provider worldwide to receive the IATA CEIV Pharma certification for the KN PharmaChain network covering 86 locations. The certification helps ensure the integrity of pharmaceutical products throughout the entire airfreight supply chain.
“With this new agreement, we were able to combine all our global forwarding services with the Kuehne + Nagel Group. This centralization and our partner’s expertise in the pharmaceutical industry will help us to make our processes more efficient and enhance our competitiveness,” said Victor Barbosa, Senior Vice President Global Supply Chain, Grünenthal.
“We are delighted with the confidence the Grünenthal Group has placed in us and look forward to future collaboration. Our aim is to reshape the entire network for logistics services together with the customer. To achieve this, we will utilise our expertise in providing services for the pharmaceutical and healthcare industry, which is of strategic importance for Kuehne + Nagel,” said Dr. Hansjörg Rodi, Managing Director, Kuehne + Nagel Germany.